The Medical Ultrasound Devices Market consists of devices which operate on the principle of diagnostic and therapeutic projection of cyclic sound waves ranging between 20KHz – 10MHz. These waves create varying pressures on biological tissue based on the level of frequencies used. Ultrasound has the ability to raise the temperature of a substance when directed in focused waves and thus also finds therapeutic applications.

Medical application of ultrasound began post 2nd world-war in the 1940’s with the first diagnostic applications being in cardiology. Today ultrasound has medical applications on every area of the body and gives very accurate results regarding the overall structural composition based on the density and transmission of the sound waves through biological tissue. Along with the conventional Black&White ultrasound imaging systems, the global market is highly prospective for color Doppler and 3-D/ 4-D imaging systems. The imaging clarity and diagnostic abilities offered by recent ultrasound devices is predicted to give a thrust to the overall global diagnostic market and support other imaging technologies such as Magnetic Resonance Imaging, Computed Tomography and PET/SPECT.

Ultrasound frequencies ranging between 0.8MHz - 3.3MHz have found use in therapeutic application in ablation of tissue. The ultrasound energy focused and directed towards unwanted tissue is transmitted harmlessly through the upper layers of tissue and focused only on the undesirable area. This raises the temperature of the tissue as large amount of sonic energy is deposited within the area. As the living cells are not able to dissipate the heat created quickly enough, the temperature rises above the survival threshold and the cells finally die due to coagulation necrosis.

Ultrasound also has other applications in movement detection for security, structural integrity of constructions, detection of wielding cracks, navigation and ranging in military and astronomy.

The market for hand-held ultrasonic devices such as “Vscan” GE healthcare (U.K), “Acuson V10” Siemens (Sweden) and by other niche players such as Mobisante (U.S) which has recently cleared the 510k status by U.S FDA are expected to propel the growth for the hand-held segment of ultrasound devices. Meanwhile the market for therapeutic Ultrasound devices such as High Intensity Focused Ultrasound HIFU, Lithotriptors and ultrasound surgical devices is driven by increasing demand from the changing trends in areas such as cosmetology, ablative procedures for uterine fibroids and lithotripsy applications in kidney stones, bladder stones and others. The Global Medical Ultrasound Devices Market for diagnostic applications is led by key market players such as G.E Healthcare (U.K), Philips Healthcare (Netherlands), Siemens (Sweden), Biosound Esaote (Italy), Toshiba (Japan), Hitachi-Aloka (Japan), Sonosite (U.S), Misonix Inc (U.S), Ultrasonix(U.S), Zonare Medical Systems (U.S) and other players such as MindRay Medical (China), Terason(U.S), Verathon(Canada), Supersonic Imagine (france), Analogic (U.S) and Tomtec (U.S).

TABLE OF CONTENTS

1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
  3.1 INTRODUCTION
  3.2 MARKET DYNAMICS
      3.2.1 DRIVERS
      3.2.2 RESTRAINTS
      3.2.3 OPPORTUNITIES
      3.2.4 TRENDS & TECHNOLOGIES
      3.2.5 MARKET SHARE ANALYSIS
      3.2.6 INDUSTRY BENCHMARKING

4 ULTRASOUND DEVICES, BY TECHNOLOGY
  4.1 INTRODUCTION
  4.2 IMAGING ULTRASOUND
      4.2.1 B/W SONOGRAPHY
            4.2.1.1 2-D
            4.2.1.2 3-D & 4-D
      4.2.2 COLOR DOPPLER
            4.2.2.1 2-D
            4.2.2.2 3-D & 4-D
  4.3 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)
  4.4 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
  4.5 ULTRASONICALLY ACTIVATED SURGICAL DEVICES

5 DIAGNOSTIC ULTRASOUND, BY APPLICATIONS
  5.1 INTRODUCTION
  5.2 IMAGING ULTRASOUND
      5.2.1 CARDIOLOGY
      5.2.2 RADIOLOGY
      5.2.3 OBSTETRICS AND GYNECOLOGY
      5.2.4 VASCULAR
      5.2.5 EMERGENCY MEDICINE
      5.2.6 MUSCULOSKELETAL
      5.2.7 ONCOLOGY
      5.2.8 COSMETOLOGY

6 THERAPEUTIC ULTRASOUND, BY APPLICATIONS
  6.1 INTRODUCTION
  6.2 HIGH INTENSITY FOCUSED ULTRASOUND
      6.2.1 CARDIOLOGY
      6.2.2 RADIOLOGY
      6.2.3 OBSTETRICS AND GYNECOLOGY
      6.2.4 VASCULAR
      6.2.5 EMERGENCY MEDICINE
      6.2.6 MUSCULOSKELETAL
      6.2.7 ONCOLOGY
      6.2.8 COSMETOLOGY
  6.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
      6.3.1 UROLOGICAL
  6.4 ULTRASONICALLY ACTIVATED SURGICAL DEVICES
      6.4.1 CARDIOLOGY
      6.4.2 RADIOLOGY
      6.4.3 OBSTETRICS AND GYNECOLOGY
      6.4.4 UROLOGY
      6.4.5 VASCULAR
      6.4.6 EMERGENCY MEDICINE
      6.4.7 MUSCULOSKELETAL
      6.4.8 ONCOLOGY
      6.4.9 COSMETOLOGY

7 ULTRASOUND DEVICES, BY PRODUCT TYPE
  7.1 INTRODUCTION
  7.2 DIAGNOSTIC ULTRASOUND DEVICES
      7.2.1 CART/TROLLEY BASED
      7.2.2 COMPACT/PORTABLE
      7.2.3 HAND-HELD
  7.3 THERAPEUTIC ULTRASOUND DEVICES
      7.3.1 HIFU
      7.3.2 ESWL
      7.3.3 UASD
            7.3.3.1 Dissectors
            7.3.3.2 Coagulators
            7.3.3.3 Aspirators

8 GEOGRAPHICAL ANALYSIS
  8.1 INTRODUCTION
  8.2 NORTH AMERICA
  8.3 EUROPE
  8.4 ASIA-PACIFIC
  8.5 ROW

9 COMPETITIVE LANDSCAPE
  9.1 MERGERS
  9.2 AQUISITIONS
  9.3 COLLABORATIONS
  9.4 RECENT DEVELOPMENTS

10 COMPANY PROFILES
  10.1 ALOKA
      10.1.1 OVERVIEW
      10.1.2 FINANCIALS
      10.1.3 PRODUCT & SERVICES
      10.1.4 STRATEGY
      10.1.5 DEVELOPMENTS
  10.2 ANALOGIC
      10.2.1 OVERVIEW
      10.2.2 FINANCIALS
      10.2.3 PRODUCT & SERVICES
      10.2.4 STRATEGY
      10.2.5 DEVELOPMENTS
  10.3 EDAP TMS
      10.3.1 OVERVIEW
      10.3.2 FINANCIALS
      10.3.3 PRODUCT & SERVICES
      10.3.4 STRATEGY
      10.3.5 DEVELOPMENTS
  10.4 ESAOTE
      10.4.1 OVERVIEW
      10.4.2 FINANCIALS
      10.4.3 PRODUCT & SERVICES
      10.4.4 STRATEGY
      10.4.5 DEVELOPMENTS
  10.5 FUKUDA DENSHI
      10.5.1 OVERVIEW
      10.5.2 FINANCIALS
      10.5.3 PRODUCT & SERVICES
      10.5.4 STRATEGY
      10.5.5 DEVELOPMENTS
  10.6 G.E HEALTHCARE
      10.6.1 OVERVIEW
      10.6.2 FINANCIALS
      10.6.3 PRODUCT & SERVICES
      10.6.4 STRATEGY
      10.6.5 DEVELOPMENTS
  10.7 HAIFU
      10.7.1 OVERVIEW
      10.7.2 FINANCIALS
      10.7.3 PRODUCT & SERVICES
      10.7.4 STRATEGY
      10.7.5 DEVELOPMENTS
  10.8 INSIGHTEC
      10.8.1 OVERVIEW
      10.8.2 FINANCIALS
      10.8.3 PRODUCT & SERVICES
      10.8.4 STRATEGY
      10.8.5 DEVELOPMENTS
  10.9 MINDRAY
      10.9.1 OVERVIEW
      10.9.2 FINANCIALS
      10.9.3 PRODUCT & SERVICES
      10.9.4 STRATEGY
      10.9.5 DEVELOPMENTS
  10.10 MISONIX
      10.10.1 OVERVIEW
      10.10.2 FINANCIALS
      10.10.3 PRODUCT & SERVICES
      10.10.4 STRATEGY
      10.10.5 DEVELOPMENTS
  10.11 PHILIPS HEALTHCARE
      10.11.1 OVERVIEW
      10.11.2 FINANCIALS
      10.11.3 PRODUCT & SERVICES
      10.11.4 STRATEGY
      10.11.5 DEVELOPMENTS
  10.12 SIEMENS
      10.12.1 OVERVIEW
      10.12.2 FINANCIALS
      10.12.3 PRODUCT & SERVICES
      10.12.4 STRATEGY
      10.12.5 DEVELOPMENTS
  10.13 SONOSCPE
      10.13.1 OVERVIEW
      10.13.2 FINANCIALS
      10.13.3 PRODUCT & SERVICES
      10.13.4 STRATEGY
      10.13.5 DEVELOPMENTS
  10.14 SONOSITE
      10.14.1 OVERVIEW
      10.14.2 FINANCIALS
      10.14.3 PRODUCT & SERVICES
      10.14.4 STRATEGY
      10.14.5 DEVELOPMENTS
  10.15 SUPERSONIC IMAGINE
      10.15.1 OVERVIEW
      10.15.2 FINANCIALS
      10.15.3 PRODUCT & SERVICES
      10.15.4 STRATEGY
      10.15.5 DEVELOPMENTS
  10.16 TERASON
      10.16.1 OVERVIEW
      10.16.2 FINANCIALS
      10.16.3 PRODUCT & SERVICES
      10.16.4 STRATEGY
      10.16.5 DEVELOPMENTS
  10.17 TOMTEC
      10.17.1 OVERVIEW
      10.17.2 FINANCIALS
      10.17.3 PRODUCT & SERVICES
      10.17.4 STRATEGY
      10.17.5 DEVELOPMENTS
  10.18 TOSHIBA MEDICAL SYSTEMS
      10.18.1 OVERVIEW
      10.18.2 FINANCIALS
      10.18.3 PRODUCT & SERVICES
      10.18.4 STRATEGY
      10.18.5 DEVELOPMENTS
  10.19 ULTRASONIX
      10.19.1 OVERVIEW
      10.19.2 FINANCIALS
      10.19.3 PRODUCT & SERVICES
      10.19.4 STRATEGY
      10.19.5 DEVELOPMENTS
  10.20 VERATHON
      10.20.1 OVERVIEW
      10.20.2 FINANCIALS
      10.20.3 PRODUCT & SERVICES
      10.20.4 STRATEGY
      10.20.5 DEVELOPMENTS
  10.21 ZONARE
      10.21.1 OVERVIEW
      10.21.2 FINANCIALS
      10.21.3 PRODUCT & SERVICES
      10.21.4 STRATEGY
      10.21.5 DEVELOPMENTS